XML 14 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Income (Loss) and Comprehensive Income (Loss) - USD ($)
shares in Millions, $ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Revenues:        
Revenues $ 296.0 $ 258.5 $ 821.5 $ 798.0
Operating expenses:        
Cost of sales 4.2 2.7 10.2 7.2
Research and development 92.7 69.1 240.7 208.3
Acquired in-process research and development 0.0 118.5 5.0 164.5
Selling, general and administrative 154.6 112.5 426.8 326.8
Total operating expenses 251.5 302.8 682.7 706.8
Operating income (loss) 44.5 (44.3) 138.8 91.2
Other (expense) income:        
Interest expense (6.6) (8.5) (19.2) (25.0)
Unrealized loss on equity securities (8.2) (7.0) (7.5) (12.2)
Investment income and other, net 0.8 2.7 3.1 11.0
Total other expense, net (14.0) (12.8) (23.6) (26.2)
Income (loss) before provision for income taxes 30.5 (57.1) 115.2 65.0
Provision for income taxes 8.0 0.5 18.3 5.6
Net income (loss) 22.5 (57.6) 96.9 59.4
Unrealized (loss) gain on debt securities available-for-sale, net of tax (0.3) (1.4) (1.4) 1.8
Comprehensive income (loss) $ 22.2 $ (59.0) $ 95.5 $ 61.2
Net income (loss) per share, basic (in USD per share) $ 0.24 $ (0.62) $ 1.03 $ 0.64
Net income (loss) per share, diluted (in USD per share) $ 0.23 $ (0.62) $ 0.99 $ 0.61
Weighted average common shares outstanding, basic (in shares) 94.7 93.3 94.5 93.0
Weighted average common shares outstanding, diluted (in shares) 97.7 93.3 97.9 98.0
Net product sales        
Revenues:        
Revenues $ 288.8 $ 254.1 $ 786.6 $ 752.8
Collaboration revenues        
Revenues:        
Revenues $ 7.2 $ 4.4 $ 34.9 $ 45.2